Penumbra, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (33)

Latest Posts

About This Stock More About This Stock
Bull Of The Day: Penumbra (PEN)
Article By: Kevin Cook
Tuesday, September 25, 2018 2:30 PM EST
Penumbra made a strong swing to sustainable profitability this year on the back of projected 27.5% sales growth from last year's $333 million to over $425 million in revenue.
In this article: PEN Also: ABT, BAX, EW, JNJ, MDT, SYK, IART, AXGN, MZOR
Read
Brave Market Volatility With These 5 Low-Beta Stocks
Article By: Zacks Investment Research
Friday, September 21, 2018 3:25 AM EST
It is a common misconception that only risky investments prove rewarding. The strategy works best when the market is bullish.
In this article: HCA, NOA, ECOL, GIII, PEN
Read
Medical Product Stocks Tuesday, May 8 Earnings List: HSIC, PEN & More
Article By: Zacks Investment Research
Tuesday, May 8, 2018 5:47 AM EST
The Medical sector has put up a stellar show so far. It is projected to rise 13.6% on 8.3% revenue growth this earnings season.
In this article: BIO, HAE, HSIC, PEN
Read
E Medical Tech M&A Analysis: Neuro, Orthopedic, Aesthetics And Specialty
Article By: Joe Kunkle
Wednesday, June 8, 2016 7:04 AM EST
In the final part of my series looking at Med-Tech M&A landscape I focus on a diverse group of names, and come to find XENT is the most compelling.
In this article: HAE, CYNO, CNMD, IART, WMGI, ZLTQ, XENT, ENTL, PEN, NVRO Also: LDRH, ZBH
Read
Short Opportunity For Penumbra Following Expiration Of Earnings Blackout Period
Article By: Don Dion
Monday, April 25, 2016 2:35 PM EST
With just 4M shares initially offered to the public, if even a few insiders sell, it could send PEN's stock price tumbling down. We suggest shorting PEN prior to the end of the blackout period to take advantage of the likely price decline.
In this article: PEN Also: BSX, JNJ, MDT, SYK
Read

PARTNER HEADLINES

Latest Tweets for $PEN

No tweets yet!